1 Market Overview

1.1 Product Overview and Scope of Valvular Heart Disease Treatment

1.2 Classification of Valvular Heart Disease Treatment by Type

1.2.1 Overview: Global Valvular Heart Disease Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Valvular Heart Disease Treatment Revenue Market Share by Type in 2021

1.2.3 Cardiac Catheterization

1.2.4 Electrocardiogram (ECG)

1.2.5 Chest X-Ray

1.2.6 Stress Test

1.2.7 Others

1.3 Global Valvular Heart Disease Treatment Market by Application

1.3.1 Overview: Global Valvular Heart Disease Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital & Clinics

1.3.3 Ambulatory Surgical Centers

1.3.4 Research Institutes

1.4 Global Valvular Heart Disease Treatment Market Size & Forecast

1.5 Global Valvular Heart Disease Treatment Market Size and Forecast by Region

1.5.1 Global Valvular Heart Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Valvular Heart Disease Treatment Market Size by Region, (2017-2022)

1.5.3 North America Valvular Heart Disease Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Valvular Heart Disease Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Valvular Heart Disease Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Valvular Heart Disease Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Valvular Heart Disease Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Valvular Heart Disease Treatment Market Drivers

1.6.2 Valvular Heart Disease Treatment Market Restraints

1.6.3 Valvular Heart Disease Treatment Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Valvular Heart Disease Treatment Product and Solutions

2.1.4 Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 B. Braun Melsungen AG

2.2.1 B. Braun Melsungen AG Details

2.2.2 B. Braun Melsungen AG Major Business

2.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Product and Solutions

2.2.4 B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 B. Braun Melsungen AG Recent Developments and Future Plans

2.3 Boston Scientific Corp.

2.3.1 Boston Scientific Corp. Details

2.3.2 Boston Scientific Corp. Major Business

2.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Product and Solutions

2.3.4 Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Boston Scientific Corp. Recent Developments and Future Plans

2.4 Medtronic

2.4.1 Medtronic Details

2.4.2 Medtronic Major Business

2.4.3 Medtronic Valvular Heart Disease Treatment Product and Solutions

2.4.4 Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Medtronic Recent Developments and Future Plans

2.5 CryoLife Inc.

2.5.1 CryoLife Inc. Details

2.5.2 CryoLife Inc. Major Business

2.5.3 CryoLife Inc. Valvular Heart Disease Treatment Product and Solutions

2.5.4 CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 CryoLife Inc. Recent Developments and Future Plans

2.6 Edwards Lifesciences Corporation

2.6.1 Edwards Lifesciences Corporation Details

2.6.2 Edwards Lifesciences Corporation Major Business

2.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product and Solutions

2.6.4 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Edwards Lifesciences Corporation Recent Developments and Future Plans

2.7 LivaNova PLC

2.7.1 LivaNova PLC Details

2.7.2 LivaNova PLC Major Business

2.7.3 LivaNova PLC Valvular Heart Disease Treatment Product and Solutions

2.7.4 LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 LivaNova PLC Recent Developments and Future Plans

2.8 Neovasc Inc.

2.8.1 Neovasc Inc. Details

2.8.2 Neovasc Inc. Major Business

2.8.3 Neovasc Inc. Valvular Heart Disease Treatment Product and Solutions

2.8.4 Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Neovasc Inc. Recent Developments and Future Plans

2.9 Micro Interventional Devices

2.9.1 Micro Interventional Devices Details

2.9.2 Micro Interventional Devices Major Business

2.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Product and Solutions

2.9.4 Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Micro Interventional Devices Recent Developments and Future Plans

2.10 Symetis SA

2.10.1 Symetis SA Details

2.10.2 Symetis SA Major Business

2.10.3 Symetis SA Valvular Heart Disease Treatment Product and Solutions

2.10.4 Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Symetis SA Recent Developments and Future Plans

2.11 Jenavalve Technology

2.11.1 Jenavalve Technology Details

2.11.2 Jenavalve Technology Major Business

2.11.3 Jenavalve Technology Valvular Heart Disease Treatment Product and Solutions

2.11.4 Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Jenavalve Technology Recent Developments and Future Plans

2.12 TTK Healthcare Limited

2.12.1 TTK Healthcare Limited Details

2.12.2 TTK Healthcare Limited Major Business

2.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Product and Solutions

2.12.4 TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 TTK Healthcare Limited Recent Developments and Future Plans

2.13 Colibri Heart Valve

2.13.1 Colibri Heart Valve Details

2.13.2 Colibri Heart Valve Major Business

2.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Product and Solutions

2.13.4 Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Colibri Heart Valve Recent Developments and Future Plans

2.14 Lepu Medical Technology Co.

2.14.1 Lepu Medical Technology Co. Details

2.14.2 Lepu Medical Technology Co. Major Business

2.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Product and Solutions

2.14.4 Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Lepu Medical Technology Co. Recent Developments and Future Plans

2.15 Braile Biomédica

2.15.1 Braile Biomédica Details

2.15.2 Braile Biomédica Major Business

2.15.3 Braile Biomédica Valvular Heart Disease Treatment Product and Solutions

2.15.4 Braile Biomédica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Braile Biomédica Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Valvular Heart Disease Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Valvular Heart Disease Treatment Players Market Share in 2021

3.2.2 Top 10 Valvular Heart Disease Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Valvular Heart Disease Treatment Players Head Office, Products and Services Provided

3.4 Valvular Heart Disease Treatment Mergers & Acquisitions

3.5 Valvular Heart Disease Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Valvular Heart Disease Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Valvular Heart Disease Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Valvular Heart Disease Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Valvular Heart Disease Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Valvular Heart Disease Treatment Revenue by Type (2017-2028)

6.2 North America Valvular Heart Disease Treatment Revenue by Application (2017-2028)

6.3 North America Valvular Heart Disease Treatment Market Size by Country

6.3.1 North America Valvular Heart Disease Treatment Revenue by Country (2017-2028)

6.3.2 United States Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Valvular Heart Disease Treatment Revenue by Type (2017-2028)

7.2 Europe Valvular Heart Disease Treatment Revenue by Application (2017-2028)

7.3 Europe Valvular Heart Disease Treatment Market Size by Country

7.3.1 Europe Valvular Heart Disease Treatment Revenue by Country (2017-2028)

7.3.2 Germany Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

7.3.3 France Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Valvular Heart Disease Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Valvular Heart Disease Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region

8.3.1 Asia-Pacific Valvular Heart Disease Treatment Revenue by Region (2017-2028)

8.3.2 China Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

8.3.5 India Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Valvular Heart Disease Treatment Revenue by Type (2017-2028)

9.2 South America Valvular Heart Disease Treatment Revenue by Application (2017-2028)

9.3 South America Valvular Heart Disease Treatment Market Size by Country

9.3.1 South America Valvular Heart Disease Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Valvular Heart Disease Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Valvular Heart Disease Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country

10.3.1 Middle East & Africa Valvular Heart Disease Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Valvular Heart Disease Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Valvular Heart Disease Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Valvular Heart Disease Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Valvular Heart Disease Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Valvular Heart Disease Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Valvular Heart Disease Treatment Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Valvular Heart Disease Treatment Product and Solutions

Table 9. Abbott Laboratories Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. B. Braun Melsungen AG Corporate Information, Head Office, and Major Competitors

Table 11. B. Braun Melsungen AG Major Business

Table 12. B. Braun Melsungen AG Valvular Heart Disease Treatment Product and Solutions

Table 13. B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Boston Scientific Corp. Corporate Information, Head Office, and Major Competitors

Table 15. Boston Scientific Corp. Major Business

Table 16. Boston Scientific Corp. Valvular Heart Disease Treatment Product and Solutions

Table 17. Boston Scientific Corp. Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Medtronic Corporate Information, Head Office, and Major Competitors

Table 19. Medtronic Major Business

Table 20. Medtronic Valvular Heart Disease Treatment Product and Solutions

Table 21. Medtronic Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. CryoLife Inc. Corporate Information, Head Office, and Major Competitors

Table 23. CryoLife Inc. Major Business

Table 24. CryoLife Inc. Valvular Heart Disease Treatment Product and Solutions

Table 25. CryoLife Inc. Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Edwards Lifesciences Corporation Corporate Information, Head Office, and Major Competitors

Table 27. Edwards Lifesciences Corporation Major Business

Table 28. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product and Solutions

Table 29. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. LivaNova PLC Corporate Information, Head Office, and Major Competitors

Table 31. LivaNova PLC Major Business

Table 32. LivaNova PLC Valvular Heart Disease Treatment Product and Solutions

Table 33. LivaNova PLC Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Neovasc Inc. Corporate Information, Head Office, and Major Competitors

Table 35. Neovasc Inc. Major Business

Table 36. Neovasc Inc. Valvular Heart Disease Treatment Product and Solutions

Table 37. Neovasc Inc. Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Micro Interventional Devices Corporate Information, Head Office, and Major Competitors

Table 39. Micro Interventional Devices Major Business

Table 40. Micro Interventional Devices Valvular Heart Disease Treatment Product and Solutions

Table 41. Micro Interventional Devices Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Symetis SA Corporate Information, Head Office, and Major Competitors

Table 43. Symetis SA Major Business

Table 44. Symetis SA Valvular Heart Disease Treatment Product and Solutions

Table 45. Symetis SA Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Jenavalve Technology Corporate Information, Head Office, and Major Competitors

Table 47. Jenavalve Technology Major Business

Table 48. Jenavalve Technology Valvular Heart Disease Treatment Product and Solutions

Table 49. Jenavalve Technology Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. TTK Healthcare Limited Corporate Information, Head Office, and Major Competitors

Table 51. TTK Healthcare Limited Major Business

Table 52. TTK Healthcare Limited Valvular Heart Disease Treatment Product and Solutions

Table 53. TTK Healthcare Limited Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Colibri Heart Valve Corporate Information, Head Office, and Major Competitors

Table 55. Colibri Heart Valve Major Business

Table 56. Colibri Heart Valve Valvular Heart Disease Treatment Product and Solutions

Table 57. Colibri Heart Valve Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Lepu Medical Technology Co. Corporate Information, Head Office, and Major Competitors

Table 59. Lepu Medical Technology Co. Major Business

Table 60. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product and Solutions

Table 61. Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Braile Biomédica Corporate Information, Head Office, and Major Competitors

Table 63. Braile Biomédica Major Business

Table 64. Braile Biomédica Valvular Heart Disease Treatment Product and Solutions

Table 65. Braile Biomédica Valvular Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Valvular Heart Disease Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Valvular Heart Disease Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Valvular Heart Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Valvular Heart Disease Treatment Players Head Office, Products and Services Provided

Table 70. Valvular Heart Disease Treatment Mergers & Acquisitions in the Past Five Years

Table 71. Valvular Heart Disease Treatment New Entrants and Expansion Plans

Table 72. Global Valvular Heart Disease Treatment Revenue (USD Million) by Type (2017-2022)

Table 73. Global Valvular Heart Disease Treatment Revenue Share by Type (2017-2022)

Table 74. Global Valvular Heart Disease Treatment Revenue Forecast by Type (2023-2028)

Table 75. Global Valvular Heart Disease Treatment Revenue by Application (2017-2022)

Table 76. Global Valvular Heart Disease Treatment Revenue Forecast by Application (2023-2028)

Table 77. North America Valvular Heart Disease Treatment Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Valvular Heart Disease Treatment Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Valvular Heart Disease Treatment Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Valvular Heart Disease Treatment Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Valvular Heart Disease Treatment Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Valvular Heart Disease Treatment Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Valvular Heart Disease Treatment Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Valvular Heart Disease Treatment Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Valvular Heart Disease Treatment Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Valvular Heart Disease Treatment Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Valvular Heart Disease Treatment Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Valvular Heart Disease Treatment Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Valvular Heart Disease Treatment Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Valvular Heart Disease Treatment Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Valvular Heart Disease Treatment Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Valvular Heart Disease Treatment Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Valvular Heart Disease Treatment Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Valvular Heart Disease Treatment Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Valvular Heart Disease Treatment Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Valvular Heart Disease Treatment Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Valvular Heart Disease Treatment Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Valvular Heart Disease Treatment Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Valvular Heart Disease Treatment Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Valvular Heart Disease Treatment Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Valvular Heart Disease Treatment Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Valvular Heart Disease Treatment Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Valvular Heart Disease Treatment Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Valvular Heart Disease Treatment Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Valvular Heart Disease Treatment Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Valvular Heart Disease Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Valvular Heart Disease Treatment Picture

Figure 2. Global Valvular Heart Disease Treatment Revenue Market Share by Type in 2021

Figure 3. Cardiac Catheterization

Figure 4. Electrocardiogram (ECG)

Figure 5. Chest X-Ray

Figure 6. Stress Test

Figure 7. Others

Figure 8. Valvular Heart Disease Treatment Revenue Market Share by Application in 2021

Figure 9. Hospital & Clinics Picture

Figure 10. Ambulatory Surgical Centers Picture

Figure 11. Research Institutes Picture

Figure 12. Global Valvular Heart Disease Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Valvular Heart Disease Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Valvular Heart Disease Treatment Revenue Market Share by Region (2017-2028)

Figure 15. Global Valvular Heart Disease Treatment Revenue Market Share by Region in 2021

Figure 16. North America Valvular Heart Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Valvular Heart Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Valvular Heart Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Valvular Heart Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Valvular Heart Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Valvular Heart Disease Treatment Market Drivers

Figure 22. Valvular Heart Disease Treatment Market Restraints

Figure 23. Valvular Heart Disease Treatment Market Trends

Figure 24. Abbott Laboratories Recent Developments and Future Plans

Figure 25. B. Braun Melsungen AG Recent Developments and Future Plans

Figure 26. Boston Scientific Corp. Recent Developments and Future Plans

Figure 27. Medtronic Recent Developments and Future Plans

Figure 28. CryoLife Inc. Recent Developments and Future Plans

Figure 29. Edwards Lifesciences Corporation Recent Developments and Future Plans

Figure 30. LivaNova PLC Recent Developments and Future Plans

Figure 31. Neovasc Inc. Recent Developments and Future Plans

Figure 32. Micro Interventional Devices Recent Developments and Future Plans

Figure 33. Symetis SA Recent Developments and Future Plans

Figure 34. Jenavalve Technology Recent Developments and Future Plans

Figure 35. TTK Healthcare Limited Recent Developments and Future Plans

Figure 36. Colibri Heart Valve Recent Developments and Future Plans

Figure 37. Lepu Medical Technology Co. Recent Developments and Future Plans

Figure 38. Braile Biomédica Recent Developments and Future Plans

Figure 39. Global Valvular Heart Disease Treatment Revenue Share by Players in 2021

Figure 40. Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 41. Global Top 3 Players Valvular Heart Disease Treatment Revenue Market Share in 2021

Figure 42. Global Top 10 Players Valvular Heart Disease Treatment Revenue Market Share in 2021

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 44. Global Valvular Heart Disease Treatment Revenue Share by Type in 2021

Figure 45. Global Valvular Heart Disease Treatment Market Share Forecast by Type (2023-2028)

Figure 46. Global Valvular Heart Disease Treatment Revenue Share by Application in 2021

Figure 47. Global Valvular Heart Disease Treatment Market Share Forecast by Application (2023-2028)

Figure 48. North America Valvular Heart Disease Treatment Sales Market Share by Type (2017-2028)

Figure 49. North America Valvular Heart Disease Treatment Sales Market Share by Application (2017-2028)

Figure 50. North America Valvular Heart Disease Treatment Revenue Market Share by Country (2017-2028)

Figure 51. United States Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Canada Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Mexico Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Europe Valvular Heart Disease Treatment Sales Market Share by Type (2017-2028)

Figure 55. Europe Valvular Heart Disease Treatment Sales Market Share by Application (2017-2028)

Figure 56. Europe Valvular Heart Disease Treatment Revenue Market Share by Country (2017-2028)

Figure 57. Germany Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. France Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. United Kingdom Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Russia Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Italy Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Asia-Pacific Valvular Heart Disease Treatment Sales Market Share by Type (2017-2028)

Figure 63. Asia-Pacific Valvular Heart Disease Treatment Sales Market Share by Application (2017-2028)

Figure 64. Asia-Pacific Valvular Heart Disease Treatment Revenue Market Share by Region (2017-2028)

Figure 65. China Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Japan Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South Korea Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. India Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Southeast Asia Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Australia Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South America Valvular Heart Disease Treatment Sales Market Share by Type (2017-2028)

Figure 72. South America Valvular Heart Disease Treatment Sales Market Share by Application (2017-2028)

Figure 73. South America Valvular Heart Disease Treatment Revenue Market Share by Country (2017-2028)

Figure 74. Brazil Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Argentina Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Middle East and Africa Valvular Heart Disease Treatment Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Valvular Heart Disease Treatment Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Country (2017-2028)

Figure 79. Turkey Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Saudi Arabia Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. UAE Valvular Heart Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source